Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 AUG 3 ... space, at the Alexandria Center, which will become the new research headquarters for ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to be New York City's life science ...
2009 JUN 22 ... is available at www.carisdx.com.
Erbitux is a registered mark of ImClone Systems
Vectibix is registered trademark of Amgen
Camptosar is a ...
2009 AUG 24 ... Pharmaceuticals announced the appointment of John H. Johnson, Chief Executive Officer of ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to the company's Board of ...
2009 NOV 23 ... Most recently, he served as Senior Vice President, General Counsel, Secretary, at ImClone Systems, Inc. where he led the legal and compliance team, and successfully structured and ...
2009 OCT 5 ... diarrhea (22%), leukopenia (17%), asthenia/malaise (16%), and acneform rash (14%) About ImClone Systems Additional information about ImClone, a wholly-owned subsidiary of Eli Lilly and ...
2009 SEP 7 ... the Company's Licensing and Funded Research Program (LFRP). LFRP licensee ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, recently announced it initiated ...
2009 MAY 25 ... Cancer, DNA, Drug Development, Genentech Inc., HIV, Human Immunodeficiency Virus, ImClone Systems, Oncology, Therapy, Treatment, Virology, CytoDyn Inc.
This article was ...
2009 MAY 25 ... the newest molecules in its portfolio resulting from Lilly's recent acquisition of ImClone Systems.
"ASCO's theme of 'Personalizing Cancer Care' is one to which ...
2009 AUG 10 ... a large family of VEGF ligands and receptors. Ramucirumab, which is being developed by ImClone Systems Inc, is a fully human mAb that binds human VEGFR-2, thus blocking VEGF binding and ...
2009 SEP 21 ... has held previous positions in oncology and neurology research at Kyowa Pharmaceuticals, ImClone Systems, and Allergan. She is a board certified neurologist with a fellowship in neuro-oncology. ...
2009 SEP 14 ... 2009;69(14):5643-5647). For additional information, contact J.R. Tonra, ImClone Systems, Division Research, 180 Varick St., New York City, NY 10014, USA. The ...
2009 JUN 22 ... exclusive of the net gain of $40,170,000 from the settlement of our litigation with ImClone Systems, for fiscal year 2008. This increase in operating expenses of $1,908,000 was primarily ...
2009 JUN 1 ... 2009;60(4):1145-1151).
For additional information, contact N. Loizos, ImClone Systems Corp., 180 Varick St., 6th Floor, New York City, NY 10014, USA.
Publisher ...
2009 JUN 15 ... Neoplasia, 2009;11(6):594-604).
For more information, contact J. Shen, ImClone Systems, New York City, NY 10014 USA..
Publisher contact information for the ...
2009 JUN 22 ... of Waksal Consulting L.L.C. in Montclair, NJ. From 1984 through July 2003, he was with ImClone Systems Inc., New York, NY, serving most recently as President, Chief Executive Officer and ...
2009 JUL 27 ... 2009;5(4):449). For additional information, contact G. Freckleton, ImClone Systems, Branchburg, NJ, USA. The publisher of the journal Plos Genetics can be ...
